{
  "ticker": "VERV",
  "year": 2022,
  "quarter": 4,
  "last_updated": "2025-04-15T16:12:15.965878",
  "count": 30,
  "transactions": [
    {
      "id": 28184,
      "issuer_name": "Verve Therapeutics, Inc.",
      "reporting_owner": "GV 2017 GP, L.L.C.",
      "reporting_owner_cik": "0001733338",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-04",
      "transaction_shares": "48583",
      "transaction_price": "0.00",
      "transaction_type": "J",
      "shares_after_transaction": "6108442"
    },
    {
      "id": 28995,
      "issuer_name": "Verve Therapeutics, Inc.",
      "reporting_owner": "GV 2017 GP, L.L.C.",
      "reporting_owner_cik": "0001733338",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-04",
      "transaction_shares": "48583",
      "transaction_price": "0.00",
      "transaction_type": "J",
      "shares_after_transaction": "6108442"
    },
    {
      "id": 53102,
      "issuer_name": "Verve Therapeutics, Inc.",
      "reporting_owner": "GV 2017 GP, L.L.C.",
      "reporting_owner_cik": "0001733338",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-04",
      "transaction_shares": "48583",
      "transaction_price": "0.00",
      "transaction_type": "J",
      "shares_after_transaction": "6108442"
    },
    {
      "id": 54413,
      "issuer_name": "Verve Therapeutics, Inc.",
      "reporting_owner": "GV 2017 GP, L.L.C.",
      "reporting_owner_cik": "0001733338",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-04",
      "transaction_shares": "48583",
      "transaction_price": "0.00",
      "transaction_type": "J",
      "shares_after_transaction": "6108442"
    },
    {
      "id": 89098,
      "issuer_name": "Verve Therapeutics, Inc.",
      "reporting_owner": "GV 2017 GP, L.L.C.",
      "reporting_owner_cik": "0001733338",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-04",
      "transaction_shares": "48583",
      "transaction_price": "0.00",
      "transaction_type": "J",
      "shares_after_transaction": "6108442"
    },
    {
      "id": 90754,
      "issuer_name": "Verve Therapeutics, Inc.",
      "reporting_owner": "GV 2017 GP, L.L.C.",
      "reporting_owner_cik": "0001733338",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-04",
      "transaction_shares": "48583",
      "transaction_price": "0.00",
      "transaction_type": "J",
      "shares_after_transaction": "6108442"
    },
    {
      "id": 132677,
      "issuer_name": "Verve Therapeutics, Inc.",
      "reporting_owner": "GV 2017 GP, L.L.C.",
      "reporting_owner_cik": "0001733338",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-04",
      "transaction_shares": "48583",
      "transaction_price": "0.00",
      "transaction_type": "J",
      "shares_after_transaction": "6108442"
    },
    {
      "id": 134559,
      "issuer_name": "Verve Therapeutics, Inc.",
      "reporting_owner": "GV 2017 GP, L.L.C.",
      "reporting_owner_cik": "0001733338",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-04",
      "transaction_shares": "48583",
      "transaction_price": "0.00",
      "transaction_type": "J",
      "shares_after_transaction": "6108442"
    },
    {
      "id": 182657,
      "issuer_name": "Verve Therapeutics, Inc.",
      "reporting_owner": "GV 2017 GP, L.L.C.",
      "reporting_owner_cik": "0001733338",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-04",
      "transaction_shares": "48583",
      "transaction_price": "0.00",
      "transaction_type": "J",
      "shares_after_transaction": "6108442"
    },
    {
      "id": 184842,
      "issuer_name": "Verve Therapeutics, Inc.",
      "reporting_owner": "GV 2017 GP, L.L.C.",
      "reporting_owner_cik": "0001733338",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-04",
      "transaction_shares": "48583",
      "transaction_price": "0.00",
      "transaction_type": "J",
      "shares_after_transaction": "6108442"
    },
    {
      "id": 28250,
      "issuer_name": "Verve Therapeutics, Inc.",
      "reporting_owner": "GV 2017 GP, L.L.C.",
      "reporting_owner_cik": "0001733338",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-02",
      "transaction_shares": "28651",
      "transaction_price": "0.00",
      "transaction_type": "J",
      "shares_after_transaction": "6206594"
    },
    {
      "id": 29061,
      "issuer_name": "Verve Therapeutics, Inc.",
      "reporting_owner": "GV 2017 GP, L.L.C.",
      "reporting_owner_cik": "0001733338",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-02",
      "transaction_shares": "28651",
      "transaction_price": "0.00",
      "transaction_type": "J",
      "shares_after_transaction": "6206594"
    },
    {
      "id": 53181,
      "issuer_name": "Verve Therapeutics, Inc.",
      "reporting_owner": "GV 2017 GP, L.L.C.",
      "reporting_owner_cik": "0001733338",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-02",
      "transaction_shares": "28651",
      "transaction_price": "0.00",
      "transaction_type": "J",
      "shares_after_transaction": "6206594"
    },
    {
      "id": 54492,
      "issuer_name": "Verve Therapeutics, Inc.",
      "reporting_owner": "GV 2017 GP, L.L.C.",
      "reporting_owner_cik": "0001733338",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-02",
      "transaction_shares": "28651",
      "transaction_price": "0.00",
      "transaction_type": "J",
      "shares_after_transaction": "6206594"
    },
    {
      "id": 89212,
      "issuer_name": "Verve Therapeutics, Inc.",
      "reporting_owner": "GV 2017 GP, L.L.C.",
      "reporting_owner_cik": "0001733338",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-02",
      "transaction_shares": "28651",
      "transaction_price": "0.00",
      "transaction_type": "J",
      "shares_after_transaction": "6206594"
    },
    {
      "id": 90868,
      "issuer_name": "Verve Therapeutics, Inc.",
      "reporting_owner": "GV 2017 GP, L.L.C.",
      "reporting_owner_cik": "0001733338",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-02",
      "transaction_shares": "28651",
      "transaction_price": "0.00",
      "transaction_type": "J",
      "shares_after_transaction": "6206594"
    },
    {
      "id": 132805,
      "issuer_name": "Verve Therapeutics, Inc.",
      "reporting_owner": "GV 2017 GP, L.L.C.",
      "reporting_owner_cik": "0001733338",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-02",
      "transaction_shares": "28651",
      "transaction_price": "0.00",
      "transaction_type": "J",
      "shares_after_transaction": "6206594"
    },
    {
      "id": 134687,
      "issuer_name": "Verve Therapeutics, Inc.",
      "reporting_owner": "GV 2017 GP, L.L.C.",
      "reporting_owner_cik": "0001733338",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-02",
      "transaction_shares": "28651",
      "transaction_price": "0.00",
      "transaction_type": "J",
      "shares_after_transaction": "6206594"
    },
    {
      "id": 182797,
      "issuer_name": "Verve Therapeutics, Inc.",
      "reporting_owner": "GV 2017 GP, L.L.C.",
      "reporting_owner_cik": "0001733338",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-02",
      "transaction_shares": "28651",
      "transaction_price": "0.00",
      "transaction_type": "J",
      "shares_after_transaction": "6206594"
    },
    {
      "id": 184982,
      "issuer_name": "Verve Therapeutics, Inc.",
      "reporting_owner": "GV 2017 GP, L.L.C.",
      "reporting_owner_cik": "0001733338",
      "reporting_owner_position": null,
      "transaction_date": "2022-11-02",
      "transaction_shares": "28651",
      "transaction_price": "0.00",
      "transaction_type": "J",
      "shares_after_transaction": "6206594"
    },
    {
      "id": 28175,
      "issuer_name": "Verve Therapeutics, Inc.",
      "reporting_owner": "GV 2017 GP, L.L.C.",
      "reporting_owner_cik": "0001733338",
      "reporting_owner_position": null,
      "transaction_date": "2022-10-31",
      "transaction_shares": "53697",
      "transaction_price": "0.00",
      "transaction_type": "J",
      "shares_after_transaction": "6267208"
    },
    {
      "id": 28986,
      "issuer_name": "Verve Therapeutics, Inc.",
      "reporting_owner": "GV 2017 GP, L.L.C.",
      "reporting_owner_cik": "0001733338",
      "reporting_owner_position": null,
      "transaction_date": "2022-10-31",
      "transaction_shares": "53697",
      "transaction_price": "0.00",
      "transaction_type": "J",
      "shares_after_transaction": "6267208"
    },
    {
      "id": 53088,
      "issuer_name": "Verve Therapeutics, Inc.",
      "reporting_owner": "GV 2017 GP, L.L.C.",
      "reporting_owner_cik": "0001733338",
      "reporting_owner_position": null,
      "transaction_date": "2022-10-31",
      "transaction_shares": "53697",
      "transaction_price": "0.00",
      "transaction_type": "J",
      "shares_after_transaction": "6267208"
    },
    {
      "id": 54399,
      "issuer_name": "Verve Therapeutics, Inc.",
      "reporting_owner": "GV 2017 GP, L.L.C.",
      "reporting_owner_cik": "0001733338",
      "reporting_owner_position": null,
      "transaction_date": "2022-10-31",
      "transaction_shares": "53697",
      "transaction_price": "0.00",
      "transaction_type": "J",
      "shares_after_transaction": "6267208"
    },
    {
      "id": 89076,
      "issuer_name": "Verve Therapeutics, Inc.",
      "reporting_owner": "GV 2017 GP, L.L.C.",
      "reporting_owner_cik": "0001733338",
      "reporting_owner_position": null,
      "transaction_date": "2022-10-31",
      "transaction_shares": "53697",
      "transaction_price": "0.00",
      "transaction_type": "J",
      "shares_after_transaction": "6267208"
    },
    {
      "id": 90732,
      "issuer_name": "Verve Therapeutics, Inc.",
      "reporting_owner": "GV 2017 GP, L.L.C.",
      "reporting_owner_cik": "0001733338",
      "reporting_owner_position": null,
      "transaction_date": "2022-10-31",
      "transaction_shares": "53697",
      "transaction_price": "0.00",
      "transaction_type": "J",
      "shares_after_transaction": "6267208"
    },
    {
      "id": 132651,
      "issuer_name": "Verve Therapeutics, Inc.",
      "reporting_owner": "GV 2017 GP, L.L.C.",
      "reporting_owner_cik": "0001733338",
      "reporting_owner_position": null,
      "transaction_date": "2022-10-31",
      "transaction_shares": "53697",
      "transaction_price": "0.00",
      "transaction_type": "J",
      "shares_after_transaction": "6267208"
    },
    {
      "id": 134533,
      "issuer_name": "Verve Therapeutics, Inc.",
      "reporting_owner": "GV 2017 GP, L.L.C.",
      "reporting_owner_cik": "0001733338",
      "reporting_owner_position": null,
      "transaction_date": "2022-10-31",
      "transaction_shares": "53697",
      "transaction_price": "0.00",
      "transaction_type": "J",
      "shares_after_transaction": "6267208"
    },
    {
      "id": 182624,
      "issuer_name": "Verve Therapeutics, Inc.",
      "reporting_owner": "GV 2017 GP, L.L.C.",
      "reporting_owner_cik": "0001733338",
      "reporting_owner_position": null,
      "transaction_date": "2022-10-31",
      "transaction_shares": "53697",
      "transaction_price": "0.00",
      "transaction_type": "J",
      "shares_after_transaction": "6267208"
    },
    {
      "id": 184809,
      "issuer_name": "Verve Therapeutics, Inc.",
      "reporting_owner": "GV 2017 GP, L.L.C.",
      "reporting_owner_cik": "0001733338",
      "reporting_owner_position": null,
      "transaction_date": "2022-10-31",
      "transaction_shares": "53697",
      "transaction_price": "0.00",
      "transaction_type": "J",
      "shares_after_transaction": "6267208"
    }
  ]
}